CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
39.10
+0.17 (0.44%)
At close: Nov 20, 2026, 4:00 PM EST
39.50
+0.40 (1.02%)
After-hours: Nov 20, 2026, 7:57 PM EST
CRISPR Therapeutics AG Market Cap
CRISPR Therapeutics AG has a market cap or net worth of $3.79 billion as of November 20, 2026. It is the 4,170th most valuable company in the world and the 1,295th biggest in the United States. Its market cap has decreased by 21.55% in one year.
Market Cap
3.79B
Enterprise Value
2.30B
1-Year Change
-21.55%
Global Rank
Country Rank
#1,295 United States
Category
ChartMarket Cap Chart
Since October 19, 2016, CRISPR Therapeutics AG's market cap has increased from $560.10M to $3.79B, an increase of 577.15%. That is a compound annual growth rate of 20.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 3.79B | -24.11% |
| Dec 31, 2025 | 5.00B | 48.76% |
| Dec 31, 2024 | 3.36B | -32.44% |
| Dec 29, 2023 | 4.97B | 56.24% |
| Dec 30, 2022 | 3.18B | -45.12% |
| Dec 31, 2021 | 5.80B | -46.39% |
| Dec 31, 2020 | 10.82B | 221.74% |
| Dec 31, 2019 | 3.36B | 126.76% |
| Dec 31, 2018 | 1.48B | 53.95% |
| Dec 29, 2017 | 963.10M | 19.42% |
| Dec 30, 2016 | 806.50M | 43.99% |
| Oct 19, 2016 (IPO) | 560.10M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Edgewise Therapeutics | 4.37B |
| Definium Therapeutics | 3.88B |
| Tango Therapeutics | 3.68B |
| Xenon Pharmaceuticals | 3.64B |
| Tarsus Pharmaceuticals | 3.60B |
| Relay Therapeutics | 3.56B |
| Parabilis Medicines | 3.44B |
| Enliven Therapeutics | 3.42B |